Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lonsurf
Lonsurf
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
BioSpace
Thu, 08/3/23 - 10:23 am
Taiho Oncology
Lonsurf
colorectal cancer
FDA
Takeda
Hutchmed
Servier Phase III colorectal cancer trial fails to meet primary endpoint
Pharmafile
Sun, 10/24/21 - 10:36 pm
Servier
colorectal cancer
clinical trials
Lonsurf
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Thu, 06/21/18 - 10:13 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Thu, 06/21/18 - 09:53 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
FDA approves Taiho Oncology's pill for metastatic colorectal cancer
BioPharma Dive
Thu, 09/24/15 - 11:31 am
FDA
metastatic colorectal cancer
Taiho Oncology
Lonsurf